중형 제약 시장 조사 - 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00018321
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 203
Buy Now

중형 의약품 시장은 2022년 US$ 690,105.2 백만에서 2028년 US$ 1,000,584.3 백만으로 성장할 것으로 예상됩니다. 2022년부터 2028년까지 연평균 6.4% 성장할 것으로 예상됩니다.



매출, 치료 영역, R&D 지출 및 범위는 글로벌 제약 산업의 중요한 부분 중 하나입니다. 중형 제약은 제약 산업의 세 범주 중 하나입니다. 제네릭 의약품 개발과 희귀질환 치료제 개발을 강조한다. 중견 제약사들의 매출 규모는 10억~100억 달러에 이른다. 만성 질환의 유병률 증가, 노인 인구의 급속한 증가, 제품 출시 및 승인의 급증은 중형 제약 시장 성장에 도움이 될 것으로 예상됩니다.



보고서는 통찰력을 제공합니다. 시장 동향, 기술 발전 및 시장 역학과 같은 다양한 매개 변수를 강조하는 중형 제약 시장에 대한 심층 분석. 또한 주요 시장 참가자의 경쟁 환경 분석과 COVID-19 대유행이 모든 주요 지역의 시장에 미치는 영향을 제공합니다. COVID-19 전염병은 세계 경제의 세 가지 주요 측면인 제조, 공급망 및 금융 시장에 영향을 미쳤습니다. 그러나 중형 제약 시장에 대한 팬데믹 영향은 처음에는 부정적이었으나 나중에 긍정적이 되었습니다. COVID-19 팬데믹 초기에 이 지역의 중형 제약 시장은 생산 및 수요에 대한 직접적인 영향, 제조 회사에 대한 재정적 영향, 공급망 및 시장. 중간 규모 제약 시장에서 대유행의 영향은 거의 예측 가능했습니다. 그 결과 전염병, 호흡기 질환, 당뇨병, 인플루엔자용 백신과 같이 환자를 돌보고 치료하는 데 필수적인 제품에 대한 수요와 자금 조달이 극도로 높아졌습니다. 그러나 비필수 의약품에 대한 예산은 제한적이거나 사용할 수 없었습니다.



전략적 통찰력



지역마다 시험 관리를 빠르게 변경했기 때문에 대부분의 고객의 요구에 따라 임상 시험 서비스를 제공할 수 있습니다. 생명 공학 회사는 현재 해당 지역에서 임상 시험을 시작하고 있습니다. 초기 발병 이후 아시아 태평양 지역의 상황은 개선되었습니다. 2020년 5월 기준으로 사이트의 97%가 환자 방문을 위해 재개되었으며 사이트의 83%가 현장 CRA 방문을 위해 열려 있습니다. 또한 중국의 병원은 예년에 비해 입원/외래 환자 방문 비율이 90%입니다. 또한, 임상 현장은 정상 운영으로 돌아가고 있습니다.



중형 제약 시장은 지역을 기준으로 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 및 중남미.



중형 의약품 시장의 수익성 있는 지역



시장 통찰력 규모 제약 시장



고령화 인구와 변화하는 사회적 행동은 일반적이고 비용이 많이 드는 장기적인 건강 문제의 꾸준한 증가에 기여합니다. 도시화가 가속화되면서 사람들은 앉아서 생활하는 생활 방식을 채택하고 있으며, 이로 인해 비만율과 당뇨병과 같은 질병 사례가 증가하고 있습니다. 세계보건기구(WHO)에 따르면 만성질환의 유병률은 2026년까지 57% 증가할 것으로 예상됩니다. 만성질환 발병률 증가로 인한 의료 시스템에 대한 수요 증가가 주요 관심사가 되었습니다. 예를 들어, 국제 당뇨병 연맹(IDF)에 따르면 북미의 당뇨병 환자 수는 2019년 약 4600만 명이었고 2045년까지 6200만 명으로 증가할 것으로 예상됩니다. 예측 기간. 팬데믹은 피트니스 시스템에 주기적으로 막대한 지장을 초래합니다. 전 세계의 의료 시설은 발병이 발생하면 집합적으로 구성할 수 있도록 준비하기를 원합니다. 따라서 만성 질환의 유병률 증가는 중간 규모 제약 시장의 성장을 촉진합니다.



유형 기반 통찰력



유형 기반 , 중형 제약 시장은 처방전과 일반 의약품으로 양분됩니다. 2022년에는 일반의약품 부문이 더 큰 시장 점유율을 차지했습니다. 가장 빠르게 성장하는 부문 중 하나가 될 것으로 예상됩니다. 이 부문의 시장 성장은 의약품 마케팅을 위한 제약 회사의 예산 할당 증가와 가처분 소득 증가에 기인합니다.



유형별 중형 제약 시장 - 2022년 및 2028년< /h3>

신약 개발 유형 기반 인사이트



신약 개발 유형에 따라 중형 제약 시장은 사내 및 아웃소싱. 아웃소싱 부문은 2022년에 더 큰 시장 점유율을 차지했습니다. 계약 개발 및 제조 조직(CDMO)에 대한 수요 증가와 시장의 신규 진입자 수가 증가함에 따라 예측 기간 동안 아웃소싱 부문의 시장 성장이 촉진될 것입니다.



제제 기반 통찰력



제제를 기준으로 중형 제약 시장은 정제 및 캡슐, 주사제, 스프레이 및 기타 제제로 분류됩니다. . 정제 및 캡슐 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다. 장기 치료에서 정제 및 캡슐의 광범위한 사용, 스프레이의 쉬운 사용, 사전 충전 및 고정 용량 주사기와 같은 혁신적인 주사 가능한 제제가 성장을 촉진할 것으로 예상됩니다. 예측 기간 동안 알약 및 캡슐 부문의 시장 점유율.



치료 클래스 기반 통찰력



치료 클래스 기반, 중형 제약 시장은 심혈관 질환, 통증 관리, 당뇨병, 암 및 기타 조건으로 분류됩니다. 당뇨병 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다. 만성 질환의 유병률 증가와 암 발병률 증가로 인해 암 부문 시장은 예측 기간 동안 빠르게 성장할 것으로 예상됩니다.


< TIP>

중형 제약 시장 참여자들은 제품 출시 및 확장을 포함하여 유기 및 무기 전략을 채택하여 그들의 발자국과 제품 포트폴리오를 전 세계적으로 확장하고 있습니다. DAIICHI SANKYO COMPANY, LIMITED; (주)에자이; Regeneron 제약, Inc; Bausch Health Companies Inc.; 썬제약공업주식회사; Alexion 제약, Inc.; 말린크로트; 엔도 파마슈티컬스 인코포레이티드; Les Laboratories Servier; 및 UCB SA는 중형 제약 시장의 선두 기업 중 하나입니다.



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are the top companies that hold the market share in mid-size pharmaceuticals market?

DAIICHI SANKYO COMPANY LIMITED and Regeneron Pharmaceuticals, Inc, are the top two companies that hold huge market shares in the mid-size pharmaceuticals market.

Who are the key players in the mid-size pharmaceuticals market?

The mid-size pharmaceuticals market majorly consists of players such as DAIICHI SANKYO COMPANY LIMITED, Eisai Co., Ltd., Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc, Sun Pharmaceutical Industries Ltd, Alexion Pharmaceuticals, Inc., Mallinckrodt, Endo Pharmaceuticals Inc., Les Laboratories Servier, UCB S.A. amongst others.

Which drug development type held the largest share in the mid-size pharmaceuticals market?

In 2021, the hip outsource held the largest share of the market, by drug development type. It is expected to report a higher CAGR of 6.7% during 2021–2028.

Which type led the mid-size pharmaceuticals market?

In 2021, the over-the-counter segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. The major driving factors for the growth of the over-the-counter segment are increasing budget allocation by pharmaceutical companies for the marketing of drugs, higher disposable income, and the rising prevalence of chronic diseases. Moreover, the increasing self-medication tendency among the population is one of the significant factors in the growth of the over-the-counter (OTC) segment.

What is the market CAGR value of the mid-size pharmaceuticals market during the forecast period?

The CAGR value of the mid-size pharmaceuticals market during the forecasted period of 2021–2028 is 6.4%.

What are the driving factors for the mid-size pharmaceuticals market across the globe?

Key factors that are driving the growth of this market are the growing prevalence of prevalence of chronic disorders and rising number of product launches and approvals are expected to drive the market during the forecast period.

What is mid-size pharmaceutical?

Mid-size pharmaceutical is among the three categories of pharmaceutical industry. The global pharmaceutical industry is segmented on the basis of their revenue, therapy area, R&D expenditure, reach etc. The mid-sized pharmaceutical companies are those companies which have their revenue in range of US$ 1 billion to US$ 10 billion. Mid-size pharmaceutical emphasizes on generic drug and development of rare disease therapies.

The List of Companies - Mid-Size Pharmaceutical Market

  1. DAIICHI SANKYO COMPANY LIMITED
  2. Eisai Co., Ltd.
  3. Bausch Health Companies Inc.
  4. Regeneron Pharmaceuticals, Inc
  5. Sun Pharmaceutical Industries Ltd
  6. Alexion Pharmaceuticals, Inc.
  7. Mallinckrodt
  8. Endo Pharmaceuticals Inc.
  9. Les Laboratories Servier
  10. UCB S.A.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports